
Eating disorders are associated with deleterious health consequences and are prevalent among emerging adult college students. The association between some measures of economic hardship (e.g., household income, food insecurity) and eating disorder symptoms is generally well established, whereas others remain understudied (e.g., housing insecurity status, financial stress, and subjective socioeconomic position), especially among emerging adults. This study aimed to (1) cross-sectionally examine the relationship between distinct economic hardship measures (household income, food insecurity status, housing insecurity status, financial stress, and subjective socioeconomic position) and the likelihood of screening positive for a probable eating disorder and (2) determine whether gender, sexual orientation, race/ethnicity, and/or weight status moderated these relationships. Participants were emerging adult college students ages 18–24 (N = 1651) participating in the 3E Study, a longitudinal cohort of emerging adult college students attending public universities in California, who completed a baseline survey between September 2023 and January 2026. We conducted multivariable logistic regressions and found that experiencing food insecurity, housing insecurity, and financial stress were associated with increased odds of screening positive for a probable eating disorder; all other economic hardship measures were not significantly related to self-reported eating disorder pathology. Findings were not significantly moderated by gender, sexual orientation, race/ethnicity, or weight status. Results highlight the need to consider food insecurity, housing insecurity, and financial stress as potential risk factors for eating disorders in racially/ethnically and socioeconomically diverse emerging adult college students. Intervening to reduce economic stressors may be a key avenue for eating disorder prevention within this population.
Transgender and gender-diverse (TGD) individuals experience an elevated risk of eating disorders compared to cisgender individuals, yet frequently encounter barriers to affirming care. To address this gap, the present study examines outpatient psychotherapists' self-reported knowledge and confidence in treating TGD individuals with eating disorders. Psychotherapists (N = 259) from Canada and the U.S. completed self-reported measures assessing practice details, TGD-specific knowledge, and clinical confidence. Psychotherapists reported regularly encountering TGD individuals in routine outpatient practice (means ranging from 0.7 to 1.0 clients per week) yet indicated low preparedness: Approximately three-quarters of clinicians reported being ‘not at all’ or ‘slightly’ knowledgeable about providing ED treatment for TGD individuals (74.3%). Similarly, 76.7% of clinicians reported being ‘not at all’ or ‘slightly’ confident in providing ED treatment for TGD individuals. This critical gap between clinical exposure and perceived preparedness has significant implications for assessment processes and quality of care. Our findings highlight an urgent need for systematic training and improved clinical systems to support gender-affirming eating disorder treatment.
Aims Avoidant/Restrictive Food Intake Disorder (ARFID) in adults is less studied than in younger populations, and prevalence estimates vary across populations and assessment methods. This systematic review and meta-analysis estimated the prevalence of positive ARFID screens or study-defined ARFID in adults and examined variation by geographical location, population characteristics, and assessment approach. Food neophobia and food selectivity were secondary narrative outcomes. Methods The review was registered in PROSPERO (CRD420251267471), conducted according to Joanna Briggs Institute guidance, and reported following PRISMA. PubMed, Embase, and the Virtual Health Library were searched without language or date restrictions. Observational studies of adults aged 18–65 years reporting prevalence of ARFID, food neophobia, or food selectivity were eligible. Two reviewers independently screened studies and extracted data. Risk of bias was assessed using JBI tools. Random-effects meta-analyses were conducted. Results Twenty-three studies (370,230 adults) were included; 20 (368,494 participants) contributed to the ARFID meta-analysis. The exploratory pooled prevalence was 19.5% (95% CI: 7.6%–41.9%; prediction interval: 0.2%–97.2%; I2 = 99.8%). The pooled point estimate was 24.8% in clinical samples and 4.1% in non-clinical samples, although population type was not a significant moderator (p = .170). Studies using the Nine Item ARFID Screen (NIAS) yielded 33.7% versus 5.8% for non-NIAS studies, but moderation remained inconclusive. Conclusion Positive ARFID screens and study-defined ARFID are frequently identified in the adult samples studied to date, but the pooled estimate should not be interpreted as general-population prevalence. Substantial clinical and methodological heterogeneity limits comparability and supports stratified interpretation and diagnostic confirmation.